Thomas Dschietzig
Department of Cardiology and Angiology
Charité
University Medicine Berlin (Campus Mitte)
Berlin
Germany
Name/email consistency: high
- Autoregulation of human relaxin-2 gene expression critically involves relaxin and glucocorticoid receptor binding to glucocorticoid response half-sites in the relaxin-2 promoter. Dschietzig, T., Bartsch, C., Wessler, S., Baumann, G., Stangl, K. Regul. Pept. (2009)
- RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway. Dschietzig, T., Bartsch, C., Baumann, G., Stangl, K. Regul. Pept. (2009)
- First clinical experience with intravenous recombinant human relaxin in compensated heart failure. Dschietzig, T., Teichman, S., Unemori, E., Wood, S., Boehmer, J., Richter, C., Baumann, G., Stangl, K. Ann. N. Y. Acad. Sci. (2009)
- Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial. Dschietzig, T., Teichman, S., Unemori, E., Wood, S., Boehmer, J., Richter, C., Baumann, G., Stangl, K. J. Card. Fail. (2009)
- Endotoxin causes pulmonary hypertension by upregulating smooth muscle endothelin type-B receptors: role of aldose reductase. Dschietzig, T., Alexiou, K., Richter, C., Bobzin, M., Baumann, G., Stangl, K., Brunner, F. Shock (2008)
- Hypoxic induction of receptor activity-modifying protein 2 alters regulation of pulmonary endothelin-1 by adrenomedullin: induction under normoxia versus inhibition under hypoxia. Dschietzig, T., Richter, C., Asswad, L., Baumann, G., Stangl, K. J. Pharmacol. Exp. Ther. (2007)
- Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics. Dschietzig, T., Bartsch, C., Baumann, G., Stangl, K. Pharmacol. Ther. (2006)
